(RNO) Renault - Overview
Exchange: PA •
Country: France •
Currency: EUR •
Type: Common Stock •
ISIN: FR0000131906
Stock: Cars, Vans, Parts, Financing, Mobility
Total Rating 21
Risk 47
Buy Signal -1.09
| Risk 5d forecast | |
|---|---|
| Volatility | 30.3% |
| Relative Tail Risk | -3.27% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.33 |
| Alpha | -50.11 |
| Character TTM | |
|---|---|
| Beta | 0.687 |
| Beta Downside | 0.724 |
| Drawdowns 3y | |
|---|---|
| Max DD | 44.62% |
| CAGR/Max DD | -0.12 |
Description: RNO Renault February 28, 2026
Renault SA (ticker RNO) designs, manufactures, sells, repairs, maintains, and leases a broad range of motor vehicles across Europe, Eurasia, Africa, the Middle East, Asia-Pacific, and the Americas. Its operations are organized into three segments: Automotive (passenger cars, light commercial vehicles, and related parts); Sales Financing (Mobilize Financial Services, offering financing, rental, and service contracts); and Mobility Services (Mobilize Beyond Automotive, delivering EV-focused mobility and energy solutions, plus used-car and B2B powertrain activities).
Key recent metrics underline the group’s transition to electrification: in 2025, Renault’s EV sales rose 32% year-over-year, capturing roughly 12% of the European EV market; revenue reached €58.5 billion, with an operating margin of 5.2%; and the company’s net debt-to-equity ratio improved to 1.1, reflecting tighter cost control amid rising raw-material prices. A primary sector driver remains the EU’s stringent CO₂ emissions standards, which are accelerating demand for electric and hybrid models while pressuring legacy ICE production.
For a deeper dive, you might explore ValueRay’s detailed analysis of RNO.
Headlines to watch out for
- European new car sales directly impact revenue
- Raw material costs pressure automotive segment margins
- EV transition success crucial for future market share
- Global economic slowdown reduces vehicle demand
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: -10.18b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA 0.02 > 1.0 |
| NWC/Revenue: 1.96% < 20% (prev 9.42%; Δ -7.45% < -1%) |
| CFO/TA 0.08 > 3% & CFO 9.50b > Net Income -10.18b |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 1.03 > 1.5 & < 3 |
| Outstanding Shares: last quarter (273.3m) vs 12m ago -5.90% < -2% |
| Gross Margin: 19.91% > 18% (prev 0.20%; Δ 1971 % > 0.5%) |
| Asset Turnover: 93.98% > 50% (prev 73.18%; Δ 20.81% > 0%) |
| Interest Coverage Ratio: -15.06 > 6 (EBITDA TTM -1.98b / Interest Expense TTM 544.0m) |
Altman Z'' -0.73
| A: 0.02 (Total Current Assets 90.71b - Total Current Liabilities 88.47b) / Total Assets 121.01b |
| B: -0.09 (Retained Earnings -10.93b / Total Assets 121.01b) |
| C: -0.07 (EBIT TTM -8.19b / Avg Total Assets 121.46b) |
| D: -0.10 (Book Value of Equity -9.80b / Total Liabilities 98.71b) |
| Altman-Z'' Score: -0.73 = B |
Beneish M -3.30
| DSRI: 0.85 (Receivables 59.40b/54.83b, Revenue 114.15b/89.21b) |
| GMI: 1.01 (GM 19.91% / 20.10%) |
| AQI: 0.68 (AQ_t 0.13 / AQ_t-1 0.19) |
| SGI: 1.28 (Revenue 114.15b / 89.21b) |
| TATA: -0.16 (NI -10.18b - CFO 9.50b) / TA 121.01b) |
| Beneish M-Score: -3.30 (Cap -4..+1) = AA |
What is the price of RNO shares?
As of March 09, 2026, the stock is trading at EUR 28.51 with a total of 1,456,351 shares traded.
Over the past week, the price has changed by -6.49%, over one month by -8.12%, over three months by -22.44% and over the past year by -36.67%.
Over the past week, the price has changed by -6.49%, over one month by -8.12%, over three months by -22.44% and over the past year by -36.67%.
Is RNO a buy, sell or hold?
Renault has no consensus analysts rating.
What are the forecasts/targets for the RNO price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 41 | 43.9% |
| Analysts Target Price | - | - |
RNO Fundamental Data Overview March 09, 2026
Market Cap USD = 9.51b (8.26b EUR * 1.1513 EUR.USD)
P/E Forward = 8.8652
P/S = 0.1427
P/B = 0.3974
P/EG = 0.6375
Revenue TTM = 114.15b EUR
EBIT TTM = -8.19b EUR
EBITDA TTM = -1.98b EUR
Long Term Debt = 4.86b EUR (from longTermDebt, last quarter)
Short Term Debt = 64.05b EUR (from shortTermDebt, last quarter)
Debt = 68.94b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 50.00b EUR (from netDebt column, last quarter)
Enterprise Value = 57.19b EUR (8.26b + Debt 68.94b - CCE 20.01b)
Interest Coverage Ratio = -15.06 (Ebit TTM -8.19b / Interest Expense TTM 544.0m)
EV/FCF = 16.79x (Enterprise Value 57.19b / FCF TTM 3.41b)
FCF Yield = 5.96% (FCF TTM 3.41b / Enterprise Value 57.19b)
FCF Margin = 2.98% (FCF TTM 3.41b / Revenue TTM 114.15b)
Net Margin = -8.92% (Net Income TTM -10.18b / Revenue TTM 114.15b)
Gross Margin = 19.91% ((Revenue TTM 114.15b - Cost of Revenue TTM 91.42b) / Revenue TTM)
Gross Margin QoQ = 18.88% (prev 19.29%)
Tobins Q-Ratio = 0.47 (Enterprise Value 57.19b / Total Assets 121.01b)
Interest Expense / Debt = 0.06% (Interest Expense 38.0m / Debt 68.94b)
Taxrate = 36.26% (198.0m / 546.0m)
NOPAT = -5.22b (EBIT -8.19b * (1 - 36.26%)) [loss with tax shield]
Current Ratio = 1.03 (Total Current Assets 90.71b / Total Current Liabilities 88.47b)
Debt / Equity = 3.32 (Debt 68.94b / totalStockholderEquity, last quarter 20.79b)
Debt / EBITDA = -25.25 (negative EBITDA) (Net Debt 50.00b / EBITDA -1.98b)
Debt / FCF = 14.68 (Net Debt 50.00b / FCF TTM 3.41b)
Total Stockholder Equity = 25.37b (last 4 quarters mean from totalStockholderEquity)
RoA = -8.38% (Net Income -10.18b / Total Assets 121.01b)
RoE = -40.12% (Net Income TTM -10.18b / Total Stockholder Equity 25.37b)
RoCE = -27.09% (EBIT -8.19b / Capital Employed (Equity 25.37b + L.T.Debt 4.86b))
RoIC = -5.56% (negative operating profit) (NOPAT -5.22b / Invested Capital 93.97b)
WACC = 0.94% (E(8.26b)/V(77.20b) * Re(8.45%) + D(68.94b)/V(77.20b) * Rd(0.06%) * (1-Tc(0.36)))
Discount Rate = 8.45% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.99%
[DCF] Terminal Value 88.43% ; FCFF base≈3.41b ; Y1≈4.20b ; Y5≈7.15b
[DCF] Fair Price = 546.3 (EV 208.35b - Net Debt 50.00b = Equity 158.35b / Shares 289.8m; r=5.90% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -50.44 | EPS CAGR: -1.23% | SUE: 0.0 | # QB: 0
Revenue Correlation: 61.46 | Revenue CAGR: 14.12% | SUE: 0.02 | # QB: 0
EPS current Year (2026-12-31): EPS=6.99 | Chg7d=-0.014 | Chg30d=-0.188 | Revisions Net=-5 | Growth EPS=+117.5% | Growth Revenue=+2.1%
EPS next Year (2027-12-31): EPS=7.49 | Chg7d=-0.028 | Chg30d=-0.291 | Revisions Net=-3 | Growth EPS=+7.1% | Growth Revenue=+1.9%
[Analyst] Revisions Ratio: -0.71 (1 Up / 6 Down within 30d for Current Year)
P/E Forward = 8.8652
P/S = 0.1427
P/B = 0.3974
P/EG = 0.6375
Revenue TTM = 114.15b EUR
EBIT TTM = -8.19b EUR
EBITDA TTM = -1.98b EUR
Long Term Debt = 4.86b EUR (from longTermDebt, last quarter)
Short Term Debt = 64.05b EUR (from shortTermDebt, last quarter)
Debt = 68.94b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 50.00b EUR (from netDebt column, last quarter)
Enterprise Value = 57.19b EUR (8.26b + Debt 68.94b - CCE 20.01b)
Interest Coverage Ratio = -15.06 (Ebit TTM -8.19b / Interest Expense TTM 544.0m)
EV/FCF = 16.79x (Enterprise Value 57.19b / FCF TTM 3.41b)
FCF Yield = 5.96% (FCF TTM 3.41b / Enterprise Value 57.19b)
FCF Margin = 2.98% (FCF TTM 3.41b / Revenue TTM 114.15b)
Net Margin = -8.92% (Net Income TTM -10.18b / Revenue TTM 114.15b)
Gross Margin = 19.91% ((Revenue TTM 114.15b - Cost of Revenue TTM 91.42b) / Revenue TTM)
Gross Margin QoQ = 18.88% (prev 19.29%)
Tobins Q-Ratio = 0.47 (Enterprise Value 57.19b / Total Assets 121.01b)
Interest Expense / Debt = 0.06% (Interest Expense 38.0m / Debt 68.94b)
Taxrate = 36.26% (198.0m / 546.0m)
NOPAT = -5.22b (EBIT -8.19b * (1 - 36.26%)) [loss with tax shield]
Current Ratio = 1.03 (Total Current Assets 90.71b / Total Current Liabilities 88.47b)
Debt / Equity = 3.32 (Debt 68.94b / totalStockholderEquity, last quarter 20.79b)
Debt / EBITDA = -25.25 (negative EBITDA) (Net Debt 50.00b / EBITDA -1.98b)
Debt / FCF = 14.68 (Net Debt 50.00b / FCF TTM 3.41b)
Total Stockholder Equity = 25.37b (last 4 quarters mean from totalStockholderEquity)
RoA = -8.38% (Net Income -10.18b / Total Assets 121.01b)
RoE = -40.12% (Net Income TTM -10.18b / Total Stockholder Equity 25.37b)
RoCE = -27.09% (EBIT -8.19b / Capital Employed (Equity 25.37b + L.T.Debt 4.86b))
RoIC = -5.56% (negative operating profit) (NOPAT -5.22b / Invested Capital 93.97b)
WACC = 0.94% (E(8.26b)/V(77.20b) * Re(8.45%) + D(68.94b)/V(77.20b) * Rd(0.06%) * (1-Tc(0.36)))
Discount Rate = 8.45% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.99%
[DCF] Terminal Value 88.43% ; FCFF base≈3.41b ; Y1≈4.20b ; Y5≈7.15b
[DCF] Fair Price = 546.3 (EV 208.35b - Net Debt 50.00b = Equity 158.35b / Shares 289.8m; r=5.90% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -50.44 | EPS CAGR: -1.23% | SUE: 0.0 | # QB: 0
Revenue Correlation: 61.46 | Revenue CAGR: 14.12% | SUE: 0.02 | # QB: 0
EPS current Year (2026-12-31): EPS=6.99 | Chg7d=-0.014 | Chg30d=-0.188 | Revisions Net=-5 | Growth EPS=+117.5% | Growth Revenue=+2.1%
EPS next Year (2027-12-31): EPS=7.49 | Chg7d=-0.028 | Chg30d=-0.291 | Revisions Net=-3 | Growth EPS=+7.1% | Growth Revenue=+1.9%
[Analyst] Revisions Ratio: -0.71 (1 Up / 6 Down within 30d for Current Year)